Who Is Funding the Science That's Too Early for Venture Capital?
April 22, 2026
Broad Institute of MIT and Harvard
#9 in Institutes and Centers
09Institution Overview
Overall
Ranking
9
13
Rank in
Research Capabilities
34
Rank in
Entrepreneurial Readiness
4
Rank in
Market Translation
Cambridge, MA
The Broad Institute of MIT and Harvard ranks ninth among 60 biomedical research institutions in the Cure Innovation Index, based in Cambridge, Massachusetts. Its profile leans toward market translation, where it places fourth, and research capabilities are strong. Entrepreneurial readiness trails by comparison. The institute supports an incubator and accelerator, holds a Clinical and Translational Science Award, and engages faculty as principal investigators in clinical trials. As a biomedical institute affiliated with two of the world's leading universities, the Broad is known for its work at the intersection of genomics and disease biology.
Ranking Metrics
Research Capabilities
Broad Institute of MIT and Harvard ranked above average for Research Capabilities, a measure of the foundational infrastructure and resources that enable an institution to conduct high-quality, innovative science. Out of the factors in this category, Broad Institute of MIT and Harvard fared best in Funding Support.
Learn MoreEntrepreneurial Readiness
Broad Institute of MIT and Harvard ranked below average for Entrepreneurial Readiness, a measure of whether the institution has built a supportive ecosystem for entrepreneurship and whether faculty are engaged in and incentivized toward commercial activity. Out of the factors in this category, Broad Institute of MIT and Harvard fared best in Faculty Engagement.
Learn MoreMarket Translation
Broad Institute of MIT and Harvard ranked above average for Market Translation, a measure of how effectively a research institution moves scientific discovery out of the lab and into real-world clinical and commercial applications. Out of the factors in this category, Broad Institute of MIT and Harvard fared best in Health Impact.
Learn More
Cure Innovation Index Methodology
From a pool of more than 6,000 institutions, the top 303 were ranked using two dozen indicators — from scientific foundation and lab infrastructure to patents, products, and partnerships — drawn from more than a dozen federal and commercial databases, an original audit of all institutions, and surveys of more than 3,300+ scientists, industry leaders, and biomedical experts.
Insights From the Cure Innovation Index
Explore by Category
Innovation isn't a single moment — it's an entire ecosystem. The Index evaluates institutions across two dozen indicators, grouped in three core domains that reveal the full picture of what it takes to turn groundbreaking science into real-world impact.
